This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...
Lineage’s COR1 targets restoration of endothelial pump function via intracameral delivery and adhesion to Descemet membrane, ...
IO Biotech published preclinical results for its cancer vaccine IO112 and plans to submit an IND to the FDA in 2025. IO Biotech has announced the publication of preclinical study results for its ...
Preclinical toxicology studies face a significant challenge: animal models cannot self-report side effects. This limitation proves particularly problematic when evaluating treatments for which subtle ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that it will present new preclinical data from its ...
LILLE, France & PARIS--(BUSINESS WIRE)--Regulatory News: Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract Research ...
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results